Trial Site Detail
Drug: |
Imatinib + AT13387 |
|||
|---|---|---|---|---|
Trial: |
A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
|||
Dana Farber Cancer Institute450 Brookline Ave |
Principal Investigator: |
Andrew Wagner |
|---|---|
Contact: |
Lynn Colicchio, RN 617-632-3989 lcolicchio@partners.org Victoria Patterson, RN 617-582-7162 vpatterson@partners.org |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Dana Farber Cancer Institute Website: |
http://www.dana-farber.org/Research/Clinical-Trials.aspx |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.